Guillaume Vaiva Selected Research

Guillaume Vaiva Research Topics

Disease

12	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 09/2023 - 07/2003
5	Treatment-Resistant Depressive Disorder 08/2023 - 03/2016
5	Wounds and Injuries (Trauma) 03/2022 - 11/2003
3	Schizophrenia (Dementia Praecox) 01/2022 - 08/2002
3	Alcoholism (Alcohol Abuse) 01/2021 - 07/2009
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 12/2018
2	Depressive Disorder (Melancholia) 02/2020 - 01/2015
2	Anxiety Disorders (Anxiety Disorder) 02/2020 - 01/2020
2	Hallucinations (Hallucination) 01/2020 - 01/2018
2	Major Depressive Disorder (Major Depressive Disorders) 01/2016 - 01/2015
2	Catatonia 05/2015 - 07/2002
1	Psychogenic Nonepileptic Seizures 01/2023
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2023
1	Medically Unexplained Symptoms 01/2023
1	COVID-19 01/2023
1	Infections 01/2023
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Pain (Aches) 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Mood Disorders (Mood Disorder) 01/2021
1	Anhedonia 01/2021
1	Mania (Manias) 01/2020
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Sleep Wake Disorders 10/2019
1	Seizures (Absence Seizure) 05/2019
1	Conversion Disorder (Astasia Abasia) 05/2019
1	Confusion (Bewilderment) 10/2018
1	Headache (Headaches) 10/2018
1	Memory Disorders (Memory Loss) 10/2018
1	Pernicious Anemia 05/2015
1	Weight Loss (Weight Reduction) 04/2015
1	Hypertension (High Blood Pressure) 07/2011
1	Delirium 06/2003
1	Opioid-Related Disorders (Opiate Addiction) 04/2002
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2002

Drug/Important Bio-Agent (IBA)

6	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2016
2	BenzodiazepinesIBA 08/2023 - 07/2009
2	Hypnotics and Sedatives (Sedatives)IBA 01/2023 - 06/2003
2	Ketamine FDA LinkGeneric 01/2022 - 03/2016
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021 - 06/2003
2	Propranolol (Inderal)FDA LinkGeneric 01/2021 - 11/2003
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2020 - 12/2018
2	Methylphenidate (Ritalin)FDA LinkGeneric 03/2016 - 04/2015
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 06/2012
2	gamma-Aminobutyric Acid (GABA)IBA 08/2006 - 02/2004
1	Hallucinogens (Psychedelics)IBA 09/2023
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	LithiumIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	ORALIT (ORS)IBA 02/2020
1	A-factor (Streptomyces)IBA 10/2019
1	SolutionsIBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 03/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2016
1	Pramipexole (Mirapex)FDA LinkGeneric 03/2016
1	Excitatory Amino Acid AntagonistsIBA 03/2016
1	Modafinil (Provigil)FDA Link 03/2016
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 05/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 04/2015
1	agomelatine (S20098)IBA 01/2015
1	Prazosin (Minipress)FDA LinkGeneric 09/2013
1	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2012
1	Triglycerides (Triacylglycerol)IBA 07/2011
1	Heroin (Diamorphine)IBA 07/2009
1	Opiate AlkaloidsIBA 07/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 08/2006
1	A 17 (A-17)IBA 07/2003
1	Amisulpride (Solian)IBA 08/2002
1	Moclobemide (Arima)IBA 04/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 07/2009
3	Transcranial Direct Current Stimulation 01/2023 - 05/2019
1	Length of Stay 03/2022
1	Contraindications 01/2022
1	Precision Medicine 01/2022
1	Tertiary Prevention 10/2019
1	Phototherapy (Light Therapy) 12/2018
1	Anesthesia 10/2018
1	Injections 02/2012
1	Liver Transplantation 07/2002